Grifols had previously denied Gotham City’s accusations, as per its February SEC filing, saying it had already replied to all of the questions raised in the latter’s reports.

Grifols shares have fallen by around 23% since Gotham City published its first report on Jan. 9, questioning the size of the company's debt, wiping around 2 billion euros ($2.15 billion) off its ...

Grifols (GFRS) has marked a major win in its legal battle against Gotham City Research after a New York federal court declined a request made by the hedge fund seeking a dismissal of a defamation ...

The owner of Gotham City Research LLC wasted no time slashing its bet against Grifols SA after the short seller’s report sparked a record plunge in the company’s stock.. The same day Grifols ...

Spain's pharmaceutical company Grifols will seek a compensation at least equivalent to the share price loss prompted by short seller Gotham City Research's Tuesday report in the lawsuit it plans ...

Gotham City's allegations dent Grifols's stock, raising doubts about its viability. Click here to read an analysis of GRFS stock now.

Spanish drugmaker Grifols has hit back at hedge fund Gotham City Research, which claimed it had fraudulently manipulated its financial reporting, with a lawsuit filed in New York. The complaint ...

Grifols SA shares fell after short-seller Gotham City Research released a new report accusing the healthcare company of transferring funds from its shareholders to a vehicle held by former executives.

Shares in Grifols fell as much as over 40% on Tuesday, wiping $3.83 billion off its market value, after hedge fund Gotham City Research questioned its accounting, prompting the Spanish drugmaker ...

Spain's pharmaceutical company Grifols will seek a compensation at least equivalent to the share price loss prompted by short seller Gotham City Research's Tuesday report in the lawsuit it plans ...